TELMISARTAN 40mg. IP + CILNIDIPINE 10mg. IP

An antihypertensive agent that helps to control high blood pressure and lowers the chances of having a stroke or heart attack. Lowers both systolic and diastolic blood pressure to a greater extent than valsartan in hypertensive patients. (William B White, 2004) An effective strategy for the treatment of hypertension and related complications. (Jun-Hwan Jo, 2021) A safe and beneficial drug for the treatment of hypertension. (Junichi Minami, 2000) A good choice in hypertensive patients with diabetes, chronic kidney disease, and in patients developing pedal edema with other calcium channel blockers. (Shete, 2016) A beneficial antihypertensive agent in hypertensive patients experiencing high blood pressure. (Sota Hayashida, 2007) Relaxes and widens blood vessels and improves the blood flow and oxygen supply to the heart. A preferred option for patients with hypertension. (Domenico Galzerano, 2010) Has a superior BP control over different angiotensin-converting enzyme inhibitors (enalapril, ramipril, perindopril). (McFarlane, 2011) Contributes to long-term antihypertensive efficacy and is well-tolerated in a broad spectrum of hypertensive patients. (Anna J Battershill, 2006) Shows a promising role in diminishing cardiovascular risk in high-risk patients. (Philippe R Akhrass, 2011) A beneficial therapeutic choice in the management of patients with hypertension. (M Sharpe, 2001)